tadalafil has been researched along with Retinal Degeneration in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Batten, A; Buys, ES; Dordea, AC; Fei, F; Gregory-Ksander, M; Mertz, J; Pasquale, LR; Sappington, RM; Schleifer, G; Wareham, LK; Yao, V | 1 |
1 other study(ies) available for tadalafil and Retinal Degeneration
Article | Year |
---|---|
Increased bioavailability of cyclic guanylate monophosphate prevents retinal ganglion cell degeneration.
Topics: Animals; Apoptosis; Cells, Cultured; Cyclic GMP; Disease Models, Animal; Female; Glaucoma; Guanylate Cyclase; Mice, Knockout; Phosphodiesterase 5 Inhibitors; Rats, Sprague-Dawley; Retinal Degeneration; Retinal Ganglion Cells; Signal Transduction; Tadalafil | 2019 |